201 related articles for article (PubMed ID: 17224997)
1. Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant.
Carrara RC; Orellana MD; Fontes AM; Palma PV; Kashima S; Mendes MR; Coutinho MA; Voltarelli JC; Covas DT
Braz J Med Biol Res; 2007 Jan; 40(1):57-67. PubMed ID: 17224997
[TBL] [Abstract][Full Text] [Related]
2. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
[TBL] [Abstract][Full Text] [Related]
3. Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia.
Zhao Z; Tang X; You Y; Li W; Liu F; Zou P
Leuk Res; 2006 Aug; 30(8):993-1003. PubMed ID: 16448696
[TBL] [Abstract][Full Text] [Related]
4. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-9 was involved in the immuno-modulatory defect of mesenchymal stem cell from chronic myeloid leukemia patients.
Zhu XS; Shi W; An GY; Zhang HM; Song YG; Li YB
Chin Med J (Engl); 2011 Aug; 124(16):2423-30. PubMed ID: 21933581
[TBL] [Abstract][Full Text] [Related]
7. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
8. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
Schulze E; Krahl R; Thalmeier K; Helbig W
Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone.
Wöhrer S; Rabitsch W; Shehata M; Kondo R; Esterbauer H; Streubel B; Sillaber C; Raderer M; Jaeger U; Zielinski C; Valent P
Anticancer Res; 2007; 27(6B):3837-41. PubMed ID: 18225540
[TBL] [Abstract][Full Text] [Related]
10. Importance of mixed chimerism to predict relapse in persistently BCR/ABL positive long survivors after allogeneic bone marrow transplantation for chronic myeloid leukemia.
Román J; Martín C; Torres A; García A; Andrés P; García MJ; Baiget M
Leuk Lymphoma; 1998 Feb; 28(5-6):541-50. PubMed ID: 9613984
[TBL] [Abstract][Full Text] [Related]
11. Mixed chimerism of bone marrow vessels (endothelial cells, myofibroblasts) following allogeneic transplantation for chronic myelogenous leukemia.
Kvasnicka HM; Wickenhauser C; Thiele J; Varus E; Hamm K; Beelen DW; Schaefer UW
Leuk Lymphoma; 2003 Feb; 44(2):321-8. PubMed ID: 12688352
[TBL] [Abstract][Full Text] [Related]
12. Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using an in situ RT-PCR assay.
Preudhomme C; Chams-Eddine L; Roumier C; Duflos-Grardel N; Denis C; Cosson A; Fenaux P
Leukemia; 1999 May; 13(5):818-23. PubMed ID: 10374889
[TBL] [Abstract][Full Text] [Related]
13. Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation.
Santini V; Zoccolante A; Bosi A; Guidi S; Saccardi R; Vannucchi AM; Martinazzo G; Bernabei PA; Ferrini PR
Haematologica; 1996; 81(3):201-7. PubMed ID: 8767524
[TBL] [Abstract][Full Text] [Related]
14. Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Alyea EP; Soiffer RJ; Roy DC; Ritz J
Blood; 1994 Oct; 84(7):2109-14. PubMed ID: 7919323
[TBL] [Abstract][Full Text] [Related]
15. BCR/ABL oncogene-induced PI3K signaling pathway leads to chronic myeloid leukemia pathogenesis by impairing immuno-modulatory function of hemangioblasts.
Li Q; Wu Y; Fang S; Wang L; Qi H; Zhang Y; Zhang J; Li W
Cancer Gene Ther; 2015 May; 22(5):227-37. PubMed ID: 25837664
[TBL] [Abstract][Full Text] [Related]
16. Autologous reconstitution with BCR-ABL-negative haematopoiesis after T cell-depleted allogeneic BMT for CML.
Serrano J; Román J; Castillejo JA; Sánchez J; Navarro JA; Martín C; Herrera C; Torres A
Bone Marrow Transplant; 1998 Sep; 22(6):599-601. PubMed ID: 9758352
[TBL] [Abstract][Full Text] [Related]
17. Detection of BCR/ABL Translocation in Bone Marrow Derived Mesenchymal Stem Cells in Egyptian CML Patients.
Gaafar TM; Raafat II; Aly AA; Mohamed NA; Farid RJ; Saad NE; El-Hawary R; Mostafaa N; Ahmed MM
Open Access Maced J Med Sci; 2015 Jun; 3(2):231-6. PubMed ID: 27275226
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation.
Eder M; Battmer K; Kafert S; Stucki A; Ganser A; Hertenstein B
Leukemia; 1999 Sep; 13(9):1383-9. PubMed ID: 10482989
[TBL] [Abstract][Full Text] [Related]
19. [Monitoring of bcr/abl fusion gene by interphase-dual-color and dual-fusion fluorescence in situ hybridization in CML after allo-HSCT].
Qian SX; Li JY; Zhang R; Hong M; Qiu HR; Li L; Xu W; Sheng RL; Wu HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):577-81. PubMed ID: 16800946
[TBL] [Abstract][Full Text] [Related]
20. Chronic myelogenous leukemia: molecular and cellular aspects.
Pasternak G; Hochhaus A; Schultheis B; Hehlmann R
J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]